Cite
HARVARD Citation
Vital, E. et al. (2022). Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials. Annals of the rheumatic diseases. 81 (7), pp. 951-961. [Online].